Hydrocodone ER

DRUG4 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Chronic PainLow Back Pain

Phase 3

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

CompletedNCT01223365

Teva Branded Pharmaceutical Products R&D, Inc.Chronic Pain

Start: 2010-10-31End: 2012-09-30Updated: 2017-06-05

Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time

CompletedNCT01240863

Teva Branded Pharmaceutical Products R&D, Inc.Chronic Pain

Start: 2010-11-30End: 2011-08-31Updated: 2017-06-05

Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain

CompletedNCT01789970

Teva Branded Pharmaceutical Products R&D, Inc.Low Back Pain

Start: 2013-03-31End: 2014-02-28Updated: 2017-06-05

Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

CompletedNCT01922739

Teva Branded Pharmaceutical Products R&D, Inc.Low Back Pain

Start: 2013-07-31End: 2014-08-31Updated: 2021-11-09